MYRIAD GENETICS INC (MYGN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for MYGN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| MYGN | Chief Operating Officer | 57 | ["Chief Operating Officer since April 30, 2025","Chief Commercial Officer from April 2022 to April 2025","President, Mental Health or President (Myriad Neuroscience) from August 2017 to April 2022","President of Myriad Autoimmune from May 2020 until September 2021","Senior Vice President and Chief Sales and Business Development Officer at Assurex Health from January 2016","Senior leadership positions with Cyberonics (now LivaNova) from 2005 to 2016","Led commercial teams with revenues approaching $500 million at Forest Pharmaceuticals","B.S. in Life Sciences with a minor in Physiology from The Pennsylvania State University"] | [] | 2026 |